JointechLabs
Karl focuses his practice in FDA Regulatory law, representing U.S. and international clients in the food
and drug industries for pharmaceuticals and OTC drugs, biologics, medical devices. He has vast
experience in the areas of regenerative medicine and has counseled numerous clients seeking FDA approval for cellular-based products to treat both humans and animals.
This person is not in any offices
JointechLabs
Jointechlabs (JTL) is an emerging worldwide leader in point-of-care regenerative medicine therapies. With their devices and technology, they enable healthcare practitioners (HCPs), and hospitals to provide safe, cost-effective non-surgical regenerative medicine therapies at the point of care without change in the infrastructure.